Shares of Enovis Co. (NYSE:ENOV - Get Free Report) hit a new 52-week low during trading on Wednesday . The stock traded as low as $30.18 and last traded at $30.60, with a volume of 1199830 shares traded. The stock had previously closed at $32.50.
Analyst Ratings Changes
Separately, Needham & Company LLC reiterated a "buy" rating and issued a $64.00 price target on shares of Enovis in a research note on Wednesday, April 9th.
Read Our Latest Stock Report on Enovis
Enovis Trading Up 0.2 %
The firm's 50 day simple moving average is $38.85 and its two-hundred day simple moving average is $42.54. The company has a quick ratio of 1.12, a current ratio of 2.27 and a debt-to-equity ratio of 0.40. The stock has a market cap of $1.83 billion, a P/E ratio of -14.65 and a beta of 1.86.
Enovis (NYSE:ENOV - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.98 earnings per share for the quarter, beating analysts' consensus estimates of $0.92 by $0.06. Enovis had a negative net margin of 5.95% and a positive return on equity of 4.39%. The business had revenue of $560.98 million during the quarter, compared to the consensus estimate of $555.14 million. As a group, equities research analysts predict that Enovis Co. will post 2.79 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Aster Capital Management DIFC Ltd bought a new stake in Enovis in the fourth quarter valued at $29,000. Quadrant Capital Group LLC lifted its position in Enovis by 53.0% in the 4th quarter. Quadrant Capital Group LLC now owns 690 shares of the company's stock valued at $30,000 after purchasing an additional 239 shares during the last quarter. UMB Bank n.a. boosted its stake in Enovis by 128.2% during the 4th quarter. UMB Bank n.a. now owns 778 shares of the company's stock valued at $34,000 after purchasing an additional 437 shares during the period. Pinnacle Bancorp Inc. grew its position in Enovis by 54.5% in the 4th quarter. Pinnacle Bancorp Inc. now owns 850 shares of the company's stock worth $37,000 after purchasing an additional 300 shares during the last quarter. Finally, Quarry LP increased its stake in shares of Enovis by 506.1% in the fourth quarter. Quarry LP now owns 897 shares of the company's stock valued at $39,000 after purchasing an additional 749 shares during the period. Institutional investors and hedge funds own 98.45% of the company's stock.
About Enovis
(
Get Free Report)
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.
Read More
Before you consider Enovis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovis wasn't on the list.
While Enovis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
